Trials / Terminated
TerminatedNCT02491970
Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol
A Single-blind, Randomized, Active-controlled, Multi-center and Phase IV Study to Evaluate the Small Airway Parameters of Fluticasone/Formoterol (Flutiform®) Compared to Fluticasone/Salmeterol in Asthma Patients
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Mundipharma Korea Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate superiority of Fluticasone/Formoterol (Flutiform®) to Fluticasone/salmeterol based on the small airway function by assessing the Impulse Oscillometic System (IOS) in uncontrolled asthma patients requiring ICS/LABA concomitant treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluticasone/Formoterol | |
| DRUG | Fluticasone/Salmeterol |
Timeline
- Start date
- 2015-08-31
- Primary completion
- 2017-04-06
- Completion
- 2017-05-01
- First posted
- 2015-07-08
- Last updated
- 2018-05-16
Source: ClinicalTrials.gov record NCT02491970. Inclusion in this directory is not an endorsement.